These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 20035895

  • 21. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
    Lee MS, Kim HS, Yeon JT, Choi SW, Chun CH, Kwak HB, Oh J.
    J Immunol; 2009 Sep 01; 183(5):3390-9. PubMed ID: 19641137
    [Abstract] [Full Text] [Related]

  • 22. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH.
    Free Radic Biol Med; 2006 May 01; 40(9):1483-93. PubMed ID: 16632109
    [Abstract] [Full Text] [Related]

  • 23. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.
    Sato K, Suematsu A, Nakashima T, Takemoto-Kimura S, Aoki K, Morishita Y, Asahara H, Ohya K, Yamaguchi A, Takai T, Kodama T, Chatila TA, Bito H, Takayanagi H.
    Nat Med; 2006 Dec 01; 12(12):1410-6. PubMed ID: 17128269
    [Abstract] [Full Text] [Related]

  • 24. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
    Park CK, Kim HJ, Kwak HB, Lee TH, Bang MH, Kim CM, Lee Y, Chung DK, Baek NI, Kim J, Lee ZH, Kim HH.
    Int Immunopharmacol; 2007 Dec 05; 7(12):1507-16. PubMed ID: 17920527
    [Abstract] [Full Text] [Related]

  • 25. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T, Hoshino M, Aoki K, Ohya K, Komano Y, Nanki T, Miyasaka N, Umezawa K.
    Arthritis Res Ther; 2007 Dec 05; 9(5):R97. PubMed ID: 17892600
    [Abstract] [Full Text] [Related]

  • 26. Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system.
    Tanaka S.
    Am J Nephrol; 2007 Dec 05; 27(5):466-78. PubMed ID: 17652963
    [Abstract] [Full Text] [Related]

  • 27. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4.
    Chang EJ, Kim HJ, Ha J, Kim HJ, Ryu J, Park KH, Kim UH, Lee ZH, Kim HM, Fisher DE, Kim HH.
    J Cell Sci; 2007 Jan 01; 120(Pt 1):166-76. PubMed ID: 17164294
    [Abstract] [Full Text] [Related]

  • 28. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos.
    Ha J, Choi HS, Lee Y, Lee ZH, Kim HH.
    Int Immunopharmacol; 2009 Jun 01; 9(6):774-80. PubMed ID: 19285574
    [Abstract] [Full Text] [Related]

  • 29. RANKL signaling in bone physiology and cancer.
    Dougall WC.
    Curr Opin Support Palliat Care; 2007 Dec 01; 1(4):317-22. PubMed ID: 18685382
    [Abstract] [Full Text] [Related]

  • 30. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.
    Bone; 2005 Jan 01; 36(1):159-72. PubMed ID: 15664014
    [Abstract] [Full Text] [Related]

  • 31. The mechanism of osteoclast differentiation induced by IL-1.
    Kim JH, Jin HM, Kim K, Song I, Youn BU, Matsuo K, Kim N.
    J Immunol; 2009 Aug 01; 183(3):1862-70. PubMed ID: 19587010
    [Abstract] [Full Text] [Related]

  • 32. RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways.
    Nakao A, Fukushima H, Kajiya H, Ozeki S, Okabe K.
    Biochem Biophys Res Commun; 2007 Jun 15; 357(4):945-50. PubMed ID: 17467668
    [Abstract] [Full Text] [Related]

  • 33. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
    Takahashi N.
    Clin Calcium; 2006 Jun 15; 16(6):940-47. PubMed ID: 16751689
    [Abstract] [Full Text] [Related]

  • 34. MicroRNA-124 regulates osteoclast differentiation.
    Lee Y, Kim HJ, Park CK, Kim YG, Lee HJ, Kim JY, Kim HH.
    Bone; 2013 Oct 15; 56(2):383-9. PubMed ID: 23867221
    [Abstract] [Full Text] [Related]

  • 35. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J, Park OJ, Lee YJ, Jung HM, Woo KM, Choi Y.
    Eur J Immunol; 2008 Jun 15; 38(6):1598-609. PubMed ID: 18421790
    [Abstract] [Full Text] [Related]

  • 36. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
    Ichikawa H, Murakami A, Aggarwal BB.
    Mol Cancer Res; 2006 Apr 15; 4(4):275-81. PubMed ID: 16603641
    [Abstract] [Full Text] [Related]

  • 37. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway.
    Huang H, Chang EJ, Ryu J, Lee ZH, Lee Y, Kim HH.
    Biochem Biophys Res Commun; 2006 Dec 08; 351(1):99-105. PubMed ID: 17052691
    [Abstract] [Full Text] [Related]

  • 38. Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling.
    Koide M, Kinugawa S, Ninomiya T, Mizoguchi T, Yamashita T, Maeda K, Yasuda H, Kobayashi Y, Nakamura H, Takahashi N, Udagawa N.
    J Bone Miner Res; 2009 Aug 08; 24(8):1469-80. PubMed ID: 19292614
    [Abstract] [Full Text] [Related]

  • 39. Bioaggregate Inhibits Osteoclast Differentiation, Fusion, and Bone Resorption In Vitro.
    Tian J, Qi W, Zhang Y, Glogauer M, Wang Y, Lai Z, Jiang H.
    J Endod; 2015 Sep 08; 41(9):1500-6. PubMed ID: 26233260
    [Abstract] [Full Text] [Related]

  • 40. VapB as a regulator of osteoclastogenesis via modulation of PLCγ2-Ca(2+)-NFAT signaling.
    Choi SW, Yeon JT, Park KI, Lee CH, Youn BS, Oh J, Lee MS.
    FEBS Lett; 2012 Feb 03; 586(3):263-9. PubMed ID: 22245675
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.